SOM.AX
Price:
$0.445
Market Cap:
$96.17M
SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. It offers SomnoDent, an oral appliance for obstructive sleep apnea; SomnoBrux, a dental guard for the treatment of teeth grinding damage; SomMorning Repositioner, which help return mandible back to its pre-treatment centric position; and SomTabs for cleaning oral devices. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.[Read more]
Industry
Medical - Devices
IPO Date
2004-08-27
Stock Exchange
ASX
Ticker
SOM.AX
According to SomnoMed Limited’s latest financial reports and current stock price. The company's current PE Ratio is -4.45. This represents a change of 4.39% compared to the average of -4.26 of the last 4 quarters.
The mean historical PE Ratio of SomnoMed Limited over the last ten years is -108.22. The current -4.45 PE Ratio has changed 311.18% with respect to the historical average. Over the past ten years (40 quarters), SOM.AX's PE Ratio was at its highest in in the June 2019 quarter at 8.05K. The PE Ratio was at its lowest in in the June 2016 quarter at -2065.22.
Average
-108.22
Median
-11.92
Minimum
-1735.60
Maximum
712.50
Discovering the peaks and valleys of SomnoMed Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 411.93%
Maximum Annual PE Ratio = 712.50
Minimum Annual Increase = -5264.58%
Minimum Annual PE Ratio = -1735.60
Year | PE Ratio | Change |
---|---|---|
2024 | -2.66 | -63.32% |
2023 | -7.26 | -56.22% |
2022 | -16.58 | -85.29% |
2021 | -112.74 | 115.08% |
2020 | -52.42 | -96.98% |
2019 | -1735.60 | -5264.58% |
2018 | 33.61 | -183.44% |
2017 | -40.28 | -105.65% |
2016 | 712.50 | 411.93% |
2015 | 139.18 | 39.55% |
The current PE Ratio of SomnoMed Limited (SOM.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.83
5-year avg
-38.33
10-year avg
-108.22
SomnoMed Limited’s PE Ratio is greater than ImpediMed Limited (-5.48), greater than Compumedics Limited (-94.08), less than SDI Limited (12.82), less than Cogstate Limited (22.65), less than Universal Biosensors, Inc. (-2.31),
Company | PE Ratio | Market cap |
---|---|---|
-5.48 | $107.29M | |
-94.08 | $48.70M | |
12.82 | $133.72M | |
22.65 | $186.22M | |
-2.31 | $28.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SomnoMed Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SomnoMed Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is SomnoMed Limited's PE Ratio?
How is the PE Ratio calculated for SomnoMed Limited (SOM.AX)?
What is the highest PE Ratio for SomnoMed Limited (SOM.AX)?
What is the 3-year average PE Ratio for SomnoMed Limited (SOM.AX)?
What is the 5-year average PE Ratio for SomnoMed Limited (SOM.AX)?
How does the current PE Ratio for SomnoMed Limited (SOM.AX) compare to its historical average?